E-viri
PDF
Recenzirano
Odprti dostop
-
Coleman, Robert L; Spirtos, Nick M; Enserro, Danielle; Herzog, Thomas J; Sabbatini, Paul; Armstrong, Deborah K; Kim, Jae-Weon; Park, Sang-Yoon; Kim, Byoung-Gie; Nam, Joo-Hyun; Fujiwara, Keiichi; Walker, Joan L; Casey, Ann C; Alvarez Secord, Angeles; Rubin, Steve; Chan, John K; DiSilvestro, Paul; Davidson, Susan A; Cohn, David E; Tewari, Krishnansu S; Basen-Engquist, Karen; Huang, Helen Q; Brady, Mark F; Mannel, Robert S
The New England journal of medicine, 11/2019, Letnik: 381, Številka: 20Journal Article
An NCI-sponsored, randomized clinical trial tested whether patients with relapsed ovarian cancer might benefit from surgical debulking of tumors followed by chemotherapy, as compared with chemotherapy alone. No significant outcome differences were noted between the patients who underwent surgery and those treated with chemotherapy alone.
